What is the best antidepressant for a 35-year-old female taking levetiracetam (Keppra)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antidepressant for a 35-Year-Old Female Taking Levetiracetam

Bupropion is the most appropriate antidepressant choice for a 35-year-old female taking levetiracetam due to its lower risk of neuropsychiatric side effects and favorable sexual side effect profile. 1, 2, 3

Rationale for Antidepressant Selection

Understanding Levetiracetam's Psychiatric Side Effect Profile

Levetiracetam is associated with significant neuropsychiatric adverse effects that must be considered when selecting an antidepressant:

  • Behavioral disturbances occur in 13.3% of adults taking levetiracetam, including agitation, hostility, and psychosis 2
  • Depression has been reported as a side effect of levetiracetam, particularly in elderly patients and those with renal impairment 4
  • The risk of psychiatric adverse effects is higher in patients with a pre-existing psychiatric history 2

Antidepressant Selection Considerations

When selecting an antidepressant for patients on levetiracetam:

  1. Avoid medications that may worsen neuropsychiatric side effects

    • Second-generation antidepressants have similar efficacy but differ in side effect profiles 1
    • Medications that increase serotonin may potentially compound the risk of behavioral disturbances
  2. Consider bupropion as first choice because:

    • Lower rate of sexual adverse events compared to SSRIs like fluoxetine or sertraline 1
    • Less likely to exacerbate the neuropsychiatric side effects of levetiracetam
    • Different mechanism of action (dopaminergic/noradrenergic) compared to serotonergic antidepressants
  3. Alternative options if bupropion is contraindicated:

    • Sertraline or escitalopram (lower rates of drug interactions)
    • Mirtazapine (if sedation is desired)

Monitoring and Follow-up

  • Begin monitoring within 1-2 weeks of initiating antidepressant therapy 1
  • Pay particular attention to:
    • Emergence of agitation, irritability, or unusual behavioral changes
    • Suicidal thoughts (risk is greater during first 1-2 months of treatment)
    • Worsening of seizure control
    • Sexual side effects and other tolerability issues

Important Considerations and Pitfalls

  • Avoid paroxetine: Higher rates of sexual dysfunction than fluoxetine, fluvoxamine, nefazodone, or sertraline 1
  • Monitor for increased seizure risk: Although most modern antidepressants have minimal impact on seizure threshold, close monitoring is essential
  • Be alert for drug interactions: While levetiracetam has fewer drug interactions than many antiepileptic drugs, monitoring is still important
  • Consider dose adjustment: If inadequate response occurs after 4-8 weeks, dose adjustment or medication change may be necessary 1
  • Watch for behavioral changes: The combination of levetiracetam and antidepressants requires vigilant monitoring for behavioral abnormalities

Special Caution

If the patient shows signs of worsening depression or behavioral changes after starting the antidepressant, consider whether levetiracetam itself may be contributing to the depressive symptoms, as it has been reported to cause depression in some patients 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Levetiracetam for managing neurologic and psychiatric disorders.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009

Research

Probable levetiracetam-associated depression in the elderly: two case reports.

The American journal of geriatric pharmacotherapy, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.